Literature DB >> 3827691

Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging.

S Starosta-Rubinstein, A B Young, K Kluin, G Hill, A M Aisen, T Gabrielsen, G J Brewer.   

Abstract

Thirty-one patients with Wilson's disease were evaluated with detailed neurologic and medical examinations. Mean age (+/- SD) at onset was 21 +/- 5 years and at examination was 28 +/- 6 years. Of the 90% of patients who were first treated with penicillamine, 31% deteriorated initially despite therapy, and half never recovered to pretherapy baseline. At the time of our evaluations, the most common neurologic findings were dysarthria (97%), dystonia (65%), dysdiadochokinesia (58%), rigidity (52%), gait and postural abnormalities (42%), and tremor (32%). Chorea and dementia were rare. Twenty-two patients underwent magnetic resonance imaging. All but one of the 19 symptomatic patients had abnormal scans. The three asymptomatic patients had normal scans. Most lesions were seen in the caudate, putamen, subcortical white matter, midbrain, and pons. Generalized brain atrophy was also common. Lesions were less common in the thalamus, cerebellar vermis, midbrain tegmentum, globus pallidus, red nucleus, and dentate nucleus. Dystonia and bradykinesia correlated with putamen lesions, and dysarthria correlated with both putamen and caudate lesions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3827691     DOI: 10.1001/archneur.1987.00520160007005

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  52 in total

1.  Diffusion MR imaging changes associated with Wilson disease.

Authors:  R N Sener
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

2.  Cranial MRI in Wilson's disease.

Authors:  L Prayer; D Wimberger; J Kramer; G Grimm; W Oder; H Imhof
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

3.  Wilson disease: Canadian perspectives on presentation and outcomes from an adult ambulatory setting.

Authors:  A Moores; Susan Fox; Anthony Lang; Gideon M Hirschfield
Journal:  Can J Gastroenterol       Date:  2012-06       Impact factor: 3.522

4.  Wilson's disease: (31)P and (1)H MR spectroscopy and clinical correlation.

Authors:  Sanjib Sinha; A B Taly; S Ravishankar; L K Prashanth; M K Vasudev
Journal:  Neuroradiology       Date:  2010-02-20       Impact factor: 2.804

5.  Wilson's disease: cranial MRI observations and clinical correlation.

Authors:  S Sinha; A B Taly; S Ravishankar; L K Prashanth; K S Venugopal; G R Arunodaya; M K Vasudev; H S Swamy
Journal:  Neuroradiology       Date:  2006-06-03       Impact factor: 2.804

6.  Atypical MR presentation of Wilson disease: a possible consequence of paramagnetic effect of copper?

Authors:  P Brugieres; C Combes; F Ricolfi; J D Degos; J Poirier; A Gaston
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

7.  CT findings in methanol intoxication.

Authors:  Mohammed Almansori; S Nizam Ahmed
Journal:  CMAJ       Date:  2007-02-27       Impact factor: 8.262

8.  Penicillamine treatment of Wilson's disease and optic neuropathy.

Authors:  A H Lee; N F Lawton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

Review 9.  Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment.

Authors:  George J Brewer
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

10.  Wilson's disease: MRI with clinical correlation.

Authors:  A C Magalhaes; P Caramelli; J R Menezes; L S Lo; L A Bacheschi; E R Barbosa; L A Rosemberg; A Magalhaes
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.